Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and ly2510924

pyrroles has been researched along with ly2510924 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arrowsmith, ER; Crane, EJ; Flynt, A; Hainsworth, JD; Hamid, O; Mace, JR; Polzer, J; Reeves, JA; Roberson, S; Stille, JR1

Trials

1 trial(s) available for pyrroles and ly2510924

ArticleYear
A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC).
    Targeted oncology, 2016, Volume: 11, Issue:5

    Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Female; Humans; Indoles; Male; Neoplasm Metastasis; Peptides, Cyclic; Pyrroles; Receptors, CXCR4; Sunitinib

2016